research Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
This study found that one year of antiandrogen treatment with spironolactone significantly decreased bone mineral density in young women with androgen excess.



